Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

European Journal of Immunology

Volumn 23, Issue 9, 1993, Pages 2242-2249

  Feltkamp, Mariet C W ^a,b   Smits, Henk L ^a   Vierboom, Michel P M ^b   Minnaar, René P ^b   De Jongh, Barteld M ^b   Drijfhout, Jan Wouter ^a   Schegget, Jan Ter ^b   Melief, Cornelis J M ^a   Kast, W Martin ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cytotoxic T lymphocyte epitope Peptide vaccination Tumor protection Peptide binding motif Papillomavirus

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ARTICLE; CANCER IMMUNIZATION; CYTOTOXIC T LYMPHOCYTE; H2 SYSTEM; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR; TUMOR IMMUNITY; VIRUS CELL TRANSFORMATION; WART VIRUS;

AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CELL LINE, TRANSFORMED; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; TUMOR VIRUS INFECTIONS; VACCINATION; VIRAL VACCINES;

EID: 0027320440     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.1830230929     Document Type: Article

References (43)

1. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells.
2. A new technique for the assay of infectivity of human adenovirus 5 DNA